Tsumura & Co., headquartered in Japan, is a global leader in Kampo medicine. The company specializes in the research, development, and production of high-quality herbal medicines. It achieves this by combining traditional Japanese medical expertise with modern pharmaceutical technology.
Date confirmed from the Tokyo Stock Exchange (JPX) announcement schedule.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Tsumura & Co. is scheduled to report its next quarterly earnings on 11/09/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Tsumura & Co. last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 86.63 JPY.
Across its last 3 earnings reports, Tsumura & Co. stock moved by ±2.5% on average the following day. The largest reaction was +5% on 05/13/2026; 3 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.